Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/15/25
End: 06/01/27
Due: 06/01/28
A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors
Phase: N/A
Priority: Normal
Start: 06/30/21
End: 11/11/22
Due: 11/11/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Focused Orticumab Research for Treating Inflammation in Coronary Arteries | NCT06927739 | Abcentra | user2@example.com | None | 2025-06-15 | 2027-06-01 | 2028-06-01 | - | - | 2025-07-14 |
| A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors | NCT04776629 | Abcentra | user2@example.com | None | 2021-06-30 | 2022-11-11 | 2023-11-11 | - | - | 2025-07-14 |